Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

Presentation TCT 2014

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

Presenter: Dierk Scheinert

September 15, 2014

Presentation TCT 2014

PRO: IN.PACT DEEP was Flawed!

Presenter: Francesco Liistro

September 15, 2014

Presentation TCT 2014

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Peter A. Schneider

September 15, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

Presentation TCT 2013

Role of Wound Perfusion Assessment in the Management of CLI

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Presenter: James Joye

October 28, 2013

Presentation TCT 2013

Existing Technologies for CLI: What More Can We Learn by Working Together?

Presenter: Kenneth Rosenfield

October 27, 2013

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

Presentation TCT 2012

Planning Infrapopliteal Intervention for CLI: Approach and Toolbox Options

Presenter: Mahmood Razavi

October 23, 2012

Presentation TCT 2012

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Con!

Presenter: Jacques Busquet

October 23, 2012

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

PRO: IN.PACT DEEP was Flawed!

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Role of Wound Perfusion Assessment in the Management of CLI

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Existing Technologies for CLI: What More Can We Learn by Working Together?

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

Planning Infrapopliteal Intervention for CLI: Approach and Toolbox Options

Debate I. Is Endovascular Intervention the First-line Therapy for CLI? Con!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content